Lawmakers push for expanded access to anti-obesity medications in New Jersey
TRENTON, NJ. – The New Jersey Senate and General Assembly are considering a new bill requiring health insurance carriers to cover prescribed anti-obesity medication approved by the U.S. Food and Drug Administration. If passed, this bill would expand access to obesity medication and improve prevention efforts for the disease.
The bill requires health insurance carriers, including insurance companies, hospital service corporations, medical service corporations, health service corporations, and health maintenance organizations, to benefit any named subscriber or other person covered under the plan for expenses incurred in obtaining prescribed anti-obesity medication.
According to the World Health Organization, obesity can lead to various non-communicable diseases such as type 2 diabetes, cardiovascular disease, hypertension, stroke, cancer, and various mental health issues. It is estimated that almost one-third of American adults and 17% of American children ages two to 19 are obese. Globally, more than one billion people are obese, with an additional 167 million expected to become obese by 2025.
The bill’s sponsor hopes that expanding access to FDA-approved anti-obesity medication, such as “Wegovy,” will make it more affordable for individuals to access this effective treatment. In addition, since 2013, the American Medical Association has recognized obesity as a disease requiring treatment and prevention efforts.
The bill would apply to all health insurance policies in which the insurer has reserved the right to change the premium. It would take effect 90 days after its enactment and apply to policies and contracts delivered, issued, executed, or renewed on or after that date.
This bill is part of a growing trend to address the obesity epidemic and related health issues in the United States. According to the Centers for Disease Control and Prevention, obesity-related medical costs in the U.S. were estimated to be $147 billion in 2008.
If passed, this bill would make it easier for individuals struggling with obesity to access the medication they need to manage their condition and lead healthier lives. However, it also sends a message that obesity is a disease that needs to be treated and prevented like any other health condition.
READ MORE
